Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N
AVE.AX - Avecho Biotechnology Ltd
Avecho Biotechnology Ltd Phase III Interim Analysis Outcome Webinar
Jun 23, 2026 / 11:30PM GMT
=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Thanks for standing by, and welcome to the Aveco Biotechnology Investor Webinar and Q&A this morning, following the announcement of positive interim analysis in its phase three insomnia program. There'll be an initial slide presentation lasting for approximately 20 minutes, followed by Q&A. So if you have a question you'd like to submit, please feel free to type it in using the Q&A function within Zoom, and we'll get to those shortly. On behalf of Aveco today, we again have CEO, Dr. Paul Gavin, and I'll hand it over to him now.
--------------------------------------------------------------------------------
Unidentified_2 [2]
----------------------------------------------------

